top of page
Browse by category
Search
NeuroBo Pharmaceuticals to initiate Phase 1 Clinical Trial of DA-1726 for obesity
The FDA has cleared NeuroBo Pharmaceuticals’ Investigational New Drug (IND) application for DA-1726, a novel, dual oxyntomodulin (OXM)...
Top 10 most read articles on Bariatric News in January 2024
It was another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the...
NLRP3-mediated inflammation leads to insulin resistance and type 2 diabetes
NLRP3 activation is associated with a pathologic inflammatory response in children with obesity and with insulin resistance increasing...
FDA reviewing ProSomnus’ EVO medical device for severe OSA
The FDA has accepted, and is in the process of reviewing, the ProSomnus’ premarket notification for its ProSomnus EVO precision medical...
Obesity Bill of Rights to define quality obesity care as the right of all adults
The National Consumers League (NCL) and National Council on Aging (NCOA) in the US have introduced the nation's first Obesity Bill of...
FDA approves USGI Medical’s pivotal study of the POSE2.0 procedure for primary obesity
The FDA has approved an USGI Medical’s Investigational Device Exemption application to conduct a pivotal study of its POSE2.0...
Journal Watch 31/01/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
How obesity dismantles mitochondria, the key mechanism behind obesity-related metabolic dysfunction
Researchers from University of California San Diego School of Medicine have shed new light on how obesity affects our mitochondria, the...
New way of fasting may protect against inflammation
Researchers at the University of Cambridge have discovered a new way that fasting helps reduce inflammation, a potentially damaging...
Obesity and alcohol are contributing to increases in CRC rates among young adults
Overweight and obesity are contributing to rising death rates from bowel cancer among people aged 25–49 years in the European Union (EU)...
Browse by tag
bottom of page